Micro Imaging Technology's Eye on the Future
January 31 2013 - 8:00AM
Marketwired
Micro Imaging Technology, Inc. (OTCQB: MMTC) MIT has developed and
patented the MIT 1000, a Microbial Identification System that
revolutionizes the pathogenic bacteria diagnostic process and can
annually save thousands of lives and tens of millions of dollars in
health care costs. This technology will identify bacteria in
minutes at a significantly lower cost per test compared to
conventional methods.
Jeffrey Nunez, MIT's Chairman and CEO, stated, "This press
release is to provide an update concerning our achievements over
the past year and a look ahead for 2013."
- We received significant financial backing from our newest Board
member, Gregg Newhuis, and others, allowing us to concentrate all
of our efforts on moving our technology and marketing strategy
forward.
- We dramatically improved our balance sheet by reducing the
amount of debt accumulated over the past three years -- 2012 shows
more than a 65% decrease in liabilities over the previous fiscal
year.
- We substantially increased our lab capacity and operations, as
well as our calculational capacity, over the past nine months which
will ultimately allow us to more rapidly increase the number of
pathogen identifiers in the MIT 1000 library.
- We submitted applications to the Association of Advanced
Communities Research Institute (AOAC RI) for Performance Test
Method Certification for the MIT 1000 for the identification of the
pathogens E. coli and Salmonella.
- We invested thousands in production design with our Hawthorne,
California-based manufacturing partner, OSI Optoelectronics -- and
received our first three commercial, ready-for-sale MIT 1000
systems in November 2012.
- We announced in December receipt of U.S. Patent Office approval
for our new trademark Micro Identification
Technologies® under which we plan to
market the MIT 1000. We invested a great deal of time and dollars
last year on our new branding -- our new logo, enhanced website and
marketing materials.
- We also invested a great deal of time, effort and dollars in
our intellectual property security and proprietary software
technology this past year.
"Have we hit every mark," Nunez asks rhetorically. "Of course
not, obviously. We are disappointed that we are not further along
in the AOAC certification process on E. coli and Salmonella. But
we've done it in proof-of-principle testing so we know it will
happen, it's not a matter of if, it's a
matter of when. And we're very optimistic
that will be this year," he stated. Nunez continued, "Perhaps one
of our greatest and most important achievements this past year has
been the development of our MIT 1000 software infrastructure. This
has significantly improved our ability to maintain and protect
sensitive data while simplifying our customers' access to our
primary product: our identifiers. This advance ensures that the
keys to our technology kingdom remain safely in our hands, securing
and safeguarding our proprietary technology."
"Meanwhile," Nunez added, "we haven't been sitting on our hands.
We have participated in many relevant trade shows this past year
and made numerous valuable contacts in the food safety arena. These
contacts have already generated interest from prominent testing
laboratories and university research programs interested in
collaborative endeavors. Discussions are in the very early
formative stages, but we intend to consider every opportunity
available to enhance our business and growth strategy. We believe
that 2013 is going to be a very exciting year for MIT."
About: Micro Imaging Technology, Inc.
Micro Imaging Technology, Inc. is a California-based public
company that is also registered to do business under the name
Micro Identification Technologies. MIT has
developed and patented the MIT-1000, a stand-alone,
optically-based, software driven system that can detect pathogenic
bacteria and complete an identification test, after culturing, in
less than five (5) minutes for pennies per test when compared to
any other conventional method. It does not rely on chemical or
biological agents, conventional processing, fluorescent tags, gas
chromatography or DNA analysis. The process requires only clean
particle-free water and a sample of the unknown bacteria. Revenues
for all rapid testing methods exceed $5 billion annually -- with
food safety accounting for over $3.5 billion, which is expected to
surpass $4.7 billion by 2015 according to BCC Research. In
addition, the recently passed "New" U.S. Food Safety Bill is
expected to further accelerate the current annual growth rate of
6.6 percent.
You can find more information about our company and about Micro
Identification Technologies™. Please visit our newly enhanced
website at www.micro-identification.com.
This release contains statements that are forward-looking in
nature. Statements that are predictive in nature, that depend upon
or refer to future events or conditions or that include words such
as "expects," "anticipates," "intends," "plans," "believes,"
"estimates," and similar expressions are forward-looking
statements. These statements are made based upon information
available to the Company as of the date of this release, and we
assume no obligation to update any such forward-looking statements.
These statements are not guarantees of future performance and
actual results could differ materially from our current
expectations. Factors that could cause or contribute to such
differences include, but are not limited to dependence on
suppliers; short product life cycles and reductions in unit selling
prices; delays in development or shipment of new products; lack of
market acceptance of our new products or services; inability to
continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and
other factors and risks associated with our business are discussed
from time to time within our filings with the Securities and
Exchange Commission, reference MMTC: www.sec.gov.
Image Available:
http://www2.marketwire.com/mw/frame_mw?attachid=2216112
CONTACT: Jeffrey Nunez President and CEO Email: Email
Contact Web Site: www.micro-identification.com Telephone:
(949) 388-4546
Micro Imaging Technology (CE) (USOTC:MMTC)
Historical Stock Chart
From Jan 2025 to Feb 2025
Micro Imaging Technology (CE) (USOTC:MMTC)
Historical Stock Chart
From Feb 2024 to Feb 2025